siRNA treatment lowers triglycerides in individuals along with rare health condition

.RESEARCH HIGHLIGHT.19 September 2024.

Plozasiran decreased triglyceride degrees through 80% and also reduced the danger of pancreatitis in individuals with consistent chylomicronemia, along with or without a hereditary diagnosis.